| Name | Title | Contact Details |
|---|
Neovia benefits from a multi-activities, multi-species and multi-areas experience. It is a reference in terms of innovative solutions in breeding.
Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.
Brundage Group is a company that provides revenue cycle solutions for hospitals, including physician advisory services, staffing solutions, and documentation education.
Levo Usa Inc is a Peachtree City, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthRisk Resource Group is a Orange, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.